MSSM - ETF AI Analysis
Top Page
Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past month, showing solid recent momentum.
Leading Holdings With Strong Gains
Several of the top positions, including companies in technology and industrials, have posted strong year-to-date gains that support the fund’s overall results.
Broad Sector Diversification
The fund spreads its investments across many sectors such as industrials, technology, health care, and financials, which helps reduce the impact if any one industry struggles.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns go toward fees instead of staying with investors.
Heavy U.S. Concentration
With the vast majority of its holdings in U.S. companies, the ETF offers limited geographic diversification and is heavily tied to the U.S. market.
Small-Mid Cap Volatility Risk
Because the ETF focuses on small- and mid-sized companies, its share price may be more volatile and sensitive to market swings than large-cap funds.
MSSM vs. SPDR S&P 500 ETF (SPY)
AUM723.18M
RegionNorth America
Expense Ratio0.62%
Beta0.97
IssuerMorgan Stanley
Inception DateDec 09, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume45,680
30 Day Avg. Volume24,030
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
70.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1815
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MSSM Summary
The Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) focuses on smaller and mid-sized U.S. companies, aiming to tap into the growth potential of the “extended market” beyond the big, well-known large caps. It doesn’t track a set index, but instead is actively managed to pick a mix of industrial, technology, and health care names such as Bloom Energy and Ciena. Investors might consider MSSM to seek higher long-term growth and add diversification to a portfolio that’s heavy in large companies. However, small and mid-cap stocks can be more volatile, so the share price can move up and down more sharply than the overall market.
How much will it cost me?The Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) has an expense ratio of 0.57%, which means you’ll pay $5.70 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small to mid-sized companies that require more research and oversight compared to passively managed ETFs.
What would affect this ETF?The MSSM ETF, with its focus on small to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns that disproportionately impact less established businesses. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.
MSSM Top 10 Holdings
MSSM leans heavily into U.S. small and mid-cap innovators, with tech and industrial names setting the tone. Rising standouts like SanDisk, Credo Technology, and Veeco are doing much of the heavy lifting, helped by upbeat earnings and solid momentum. Comfort Systems and Plexus add a steady industrial backbone, quietly supporting returns. On the flip side, Ascendis Pharma and ViaSat have been more mixed, with profitability and leverage issues occasionally tripping up the fund. Overall, the ETF’s story is a tech-tilted, domestically focused bet on emerging growth leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Ascendis Pharma | 1.00% | $7.46M | $17.12B | 52.24% | 46 Neutral | |
| SanDisk Corp | 0.96% | $7.19M | $258.42B | 3678.28% | 55 Neutral | |
| FTAI Aviation | 0.84% | $6.25M | $25.45B | 116.65% | 58 Neutral | |
| TechnipFMC | 0.80% | $5.96M | $26.61B | 92.78% | 80 Outperform | |
| ViaSat | 0.80% | $5.96M | $11.34B | 426.05% | 56 Neutral | |
| Veeco | 0.65% | $4.85M | $3.51B | 150.12% | 70 Neutral | |
| Regal Rexnord | 0.63% | $4.74M | $14.54B | 41.54% | 69 Neutral | |
| Plexus | 0.58% | $4.35M | $7.36B | 87.67% | 75 Outperform | |
| Dynatrace | 0.57% | $4.29M | $13.05B | -19.63% | 77 Outperform | |
| KBR | 0.56% | $4.19M | $4.62B | -22.57% | 73 Outperform |
MSSM Technical Analysis
Neutral
―
Price Trends
58.98
Positive
56.34
Positive
53.68
Positive
Market Momentum
0.53
Positive
48.38
Neutral
35.18
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MSSM, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 60.33, equal to the 50-day MA of 58.98, and equal to the 200-day MA of 53.68, indicating a neutral trend. The MACD of 0.53 indicates Positive momentum. The RSI at 48.38 is Neutral, neither overbought nor oversold. The STOCH value of 35.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MSSM.
MSSM Peer Comparison
Comparison Results
Performance Comparison
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
59.73
13.20
28.37%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
MGMT
Ballast Small/Mid Cap ETF
―
―
―
RNIN
Bushido Capital US SMID Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents